Correlation analysis of the inflammatory composite index in patients with coronary heart disease

Fengqi Liu1, Shutong Ding2, Aohui Chen1

  • 1Department of Cardiology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China; Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.

Insights

The inflammatory composite index (ICI) is linked to acute coronary syndrome (ACS) in heart disease patients. Combining ICI with total cholesterol improves diagnostic accuracy for ACS.

Area of Science:

  • Cardiology
  • Biomarkers
  • Inflammation

Background:

  • Coronary heart disease (CHD) poses a significant global health burden.
  • Identifying reliable biomarkers for acute coronary syndrome (ACS) is crucial for timely intervention.
  • The inflammatory composite index (ICI), derived from neutrophil count and free triiodothyronine, warrants investigation for its role in CHD.

Purpose of the Study:

  • To explore the association between the inflammatory composite index (ICI) and coronary heart disease (CHD).
  • To evaluate the diagnostic efficacy of ICI, alone and in combination with total cholesterol (TC), for acute coronary syndrome (ACS).

Main Methods:

  • A retrospective study involving 1481 CHD patients (Jiangnan University) and 810 CHD patients (Soochow University).
  • Patients were categorized into acute coronary syndrome (ACS) and chronic coronary syndromes (CCS) groups.
  • Binary logistic regression and ROC curve analysis were employed to assess risk factors and diagnostic value.

Main Results:

  • The ICI was significantly higher in the ACS group compared to the CCS group (p < 0.001).
  • ICI was identified as an independent risk factor for ACS in CHD patients (OR=1.099, p < 0.001).
  • Combined ICI and TC demonstrated superior diagnostic accuracy (AUC=0.740) compared to either marker alone (AUC=0.693 for ICI, AUC=0.676 for TC).

Conclusions:

  • The inflammatory composite index (ICI) is significantly correlated with the occurrence of ACS in patients with coronary heart disease.
  • ICI holds potential as a diagnostic biomarker for ACS.
  • Combining ICI with total cholesterol enhances diagnostic performance for ACS in CHD patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
199
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
850
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
307
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
448
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
370
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
521